J. Gerloff

540 total citations
21 papers, 430 citations indexed

About

J. Gerloff is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Organic Chemistry. According to data from OpenAlex, J. Gerloff has authored 21 papers receiving a total of 430 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Pulmonary and Respiratory Medicine and 4 papers in Organic Chemistry. Recurrent topics in J. Gerloff's work include Chemical Synthesis and Analysis (5 papers), Veterinary Pharmacology and Anesthesia (3 papers) and Blood properties and coagulation (2 papers). J. Gerloff is often cited by papers focused on Chemical Synthesis and Analysis (5 papers), Veterinary Pharmacology and Anesthesia (3 papers) and Blood properties and coagulation (2 papers). J. Gerloff collaborates with scholars based in Germany, United States and Australia. J. Gerloff's co-authors include H. J. Dengler, W. D. Paar, W Lintz, Horst Beier, H. Möhrle, A Mignot, K. Heintze, H. Barth, David J. Greenblatt and Hermann R. Ochs and has published in prestigious journals such as Journal of Clinical Oncology, European Urology and Clinical Pharmacology & Therapeutics.

In The Last Decade

J. Gerloff

20 papers receiving 397 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J. Gerloff Germany	11	115	85	84	77	73	21	430
Rosario Calvo Spain	12	94 0.8×	77 0.9×	93 1.1×	62 0.8×	70 1.0×	30	470
H Andrew Strong Canada	12	21 0.2×	42 0.5×	164 2.0×	73 0.9×	176 2.4×	18	722
Michael N. Hartnett United States	7	23 0.2×	17 0.2×	60 0.7×	53 0.7×	114 1.6×	9	453
Marie-Paule Gascon Switzerland	8	11 0.1×	70 0.8×	180 2.1×	51 0.7×	69 0.9×	9	448
Evelyn Jones United States	10	16 0.1×	73 0.9×	97 1.2×	27 0.4×	47 0.6×	10	418
U Kersten Germany	14	18 0.2×	360 4.2×	34 0.4×	159 2.1×	102 1.4×	37	596
S A Bai United States	12	34 0.3×	27 0.3×	113 1.3×	20 0.3×	87 1.2×	18	369
Margareta Bielenstein Sweden	11	12 0.1×	67 0.8×	52 0.6×	104 1.4×	58 0.8×	13	456
DG Shand United States	10	9 0.1×	38 0.4×	97 1.2×	40 0.5×	77 1.1×	13	424
J. P. Gagnol France	12	31 0.3×	57 0.7×	10 0.1×	144 1.9×	116 1.6×	22	394

Countries citing papers authored by J. Gerloff

Since Specialization

Citations

This map shows the geographic impact of J. Gerloff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Gerloff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Gerloff more than expected).

Fields of papers citing papers by J. Gerloff

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Gerloff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Gerloff. The network helps show where J. Gerloff may publish in the future.

Co-authorship network of co-authors of J. Gerloff

This figure shows the co-authorship network connecting the top 25 collaborators of J. Gerloff. A scholar is included among the top collaborators of J. Gerloff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Gerloff. J. Gerloff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wirth, Manfred, Axel Heidenreich, Jürgen E. Gschwend, et al.. (2013). A Multicenter Phase 1 Study of EMD 525797 (DI17E6), a Novel Humanized Monoclonal Antibody Targeting αv Integrins, in Progressive Castration-resistant Prostate Cancer with Bone Metastases After Chemotherapy. European Urology. 65(5). 897–904. 38 indexed citations

Rohde, Carmen, Alena Gerlinde Thiele, Ulrike Mütze, et al.. (2013). PKU patients on a relaxed diet may be at risk for micronutrient deficiencies. European Journal of Clinical Nutrition. 68(1). 119–124. 28 indexed citations

Wirth, Manfred, Axel Heidenreich, Jürgen E. Gschwend, et al.. (2012). Final analysis: A multicenter phase I study of EMD 525797 (DI17E6), a novel humanized monoclonal antibody to human αv integrins, in progressive castrate-resistant prostate cancer with bone metastases after chemotherapy.. Journal of Clinical Oncology. 30(5_suppl). 231–231. 3 indexed citations

Lintz, W, R. H. A. Becker, J. Gerloff, & Rolf Terlinden. (2011). Pharmacokinetics of Tramadol and Bioavailability of Enteral Tramadol Formulations 4th Communication: Drops (without ethanol). Arzneimittelforschung. 50(2). 99–108. 9 indexed citations

Paar, W. D., et al.. (1997). Polymorphic CYP2D6 mediates O -demethylation of the opioid analgesic tramadol. European Journal of Clinical Pharmacology. 53(3-4). 235–239. 128 indexed citations

Gerloff, J.. (1997). Optimization of Methods and Models in Clinical Pharmacology. The Journal of Clinical Pharmacology. 37(S1). 4S–7S. 1 indexed citations

Vohra, Jitendra K., et al.. (1996). Radiofrequency ablation of idiopathic ventricular tachycardia. Australian and New Zealand Journal of Medicine. 26(2). 186–194. 3 indexed citations

Gerloff, J., A Mignot, H. Barth, & K. Heintze. (1996). Pharmacokinetics and absolute bioavailability of lansoprazole. European Journal of Clinical Pharmacology. 50(4). 293–297. 36 indexed citations

Gerloff, J., Wolfgang A. Günzler, Horst Beier, et al.. (1995). Effects of changing liver blood flow by exercise and food on kinetics and dynamics of saruplase*. Clinical Pharmacology & Therapeutics. 57(4). 381–389. 17 indexed citations

10.

Vohra, Jitendra K., et al.. (1993). Radiofrequency catheter ablation for paroxysmal supraventricular tachycardia: a report of 135 procedures. Australian and New Zealand Journal of Medicine. 23(3). 317–324. 7 indexed citations

11.

Boer, Angela G. E. M. de, C. Kluft, J. Gerloff, et al.. (1993). Pharmacokinetics of Saruplase, a Recombinant Unglycosylated Human Single-Chain Urokinase-Type Plasminogen Activator and Its Effects on Fibrinolytic and Haemostatic Parameters in Healthy Male Subjects. Thrombosis and Haemostasis. 70(2). 320–325. 10 indexed citations

12.

Ochs, Hermann R., et al.. (1985). Cerebrospinal fluid uptake and peripheral distribution of centrally acting drugs: Relation to lipid solubility. Journal of Pharmacy and Pharmacology. 37(6). 428–431. 32 indexed citations

13.

Ochs, Hermann R., et al.. (1984). Nifedipine: Kinetics and dynamics after single oral doses. Journal of Molecular Medicine. 62(9). 427–429. 16 indexed citations

14.

Jelinek, V. Michael, et al.. (1982). Assessment of cardiac risk 10 days after uncomplicated myocardial infarction.. BMJ. 284(6311). 227–230. 27 indexed citations

15.

Budde, Ulrich, et al.. (1979). Therapie einer refrakt�ren idiopathisch-thrombozytopenischen purpura mit vinblastin-beladenen thrombozyten. Annals of Hematology. 38(2). 139–141. 5 indexed citations

16.

Möhrle, H. & J. Gerloff. (1979). Oxidative Ringspaltung aromatisch substituierter 7‐ und 8‐Ring‐Heterocyclen. Archiv der Pharmazie. 312(3). 219–230. 8 indexed citations

17.

Möhrle, H. & J. Gerloff. (1979). 1,2‐Cyclisch substituierte 1,4‐Dihydrochinazoline. Archiv der Pharmazie. 312(10). 838–842. 1 indexed citations

18.

Möhrle, H. & J. Gerloff. (1978). Oxidation cyclischer aromatischer Amine. Archiv der Pharmazie. 311(8). 672–678. 6 indexed citations

19.

Möhrle, H. & J. Gerloff. (1978). Tricyclische Benzimidazolderivate. Archiv der Pharmazie. 311(5). 381–393. 12 indexed citations

20.

Kaulla, Kurt N. von & J. Gerloff. (1972). In vitro-Hemmung der durch Fremdserum induzierten Thrombocytenaggregation. Research in Experimental Medicine. 158(2). 152–164.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact